These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1898737

  • 1. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.
    Bartha K, Declerck PJ, Moreau H, Nelles L, Collen D.
    J Biol Chem; 1991 Jan 15; 266(2):792-7. PubMed ID: 1898737
    [Abstract] [Full Text] [Related]

  • 2. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
    Russell ME, Quertermous T, Declerck PJ, Collen D, Haber E, Homcy CJ.
    J Biol Chem; 1990 Feb 15; 265(5):2569-75. PubMed ID: 2105930
    [Abstract] [Full Text] [Related]

  • 3. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
    Ramakrishnan V, Sinicropi DV, Dere R, Darbonne WC, Bechtol KB, Baker JB.
    J Biol Chem; 1990 Feb 15; 265(5):2755-62. PubMed ID: 2105933
    [Abstract] [Full Text] [Related]

  • 4. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator.
    Lijnen HR, Van Hoef B, Collen D.
    J Biol Chem; 1991 Mar 05; 266(7):4041-4. PubMed ID: 1900284
    [Abstract] [Full Text] [Related]

  • 5. Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture.
    Shatos MA, Doherty JM, Stump DC, Thompson EA, Collen D.
    J Biol Chem; 1990 Nov 25; 265(33):20443-8. PubMed ID: 2122975
    [Abstract] [Full Text] [Related]

  • 6. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR, Podor TJ, Dunne E, Mimuro J, Loskutoff DJ.
    J Cell Biol; 1990 Jan 25; 110(1):155-63. PubMed ID: 2104856
    [Abstract] [Full Text] [Related]

  • 7. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells.
    Rosenfeld L, Kuo A, Hirsh J, Klugherz B, Gardell SJ, Cines DB, Barnathan ES.
    Blood; 1992 Sep 15; 80(6):1486-95. PubMed ID: 1520875
    [Abstract] [Full Text] [Related]

  • 8. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals.
    Shatos MA, Doherty JM, Orfeo T, Hoak JC, Collen D, Stump DC.
    J Biol Chem; 1992 Jan 05; 267(1):597-601. PubMed ID: 1730619
    [Abstract] [Full Text] [Related]

  • 9. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
    Fukao H, Ueshima S, Tanaka N, Okada K, Matsuo O.
    Thromb Res Suppl; 1990 Jan 05; 10():11-20. PubMed ID: 2107596
    [Abstract] [Full Text] [Related]

  • 10. Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.
    Fujii S, Sobel BE.
    Thromb Haemost; 1992 Feb 03; 67(2):233-8. PubMed ID: 1621243
    [Abstract] [Full Text] [Related]

  • 11. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y, Okada M, Noro A, Matsuda M.
    J Biol Chem; 1988 Feb 05; 263(4):1960-9. PubMed ID: 3123483
    [Abstract] [Full Text] [Related]

  • 12. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
    Fujii S, Lucore CL, Hopkins WE, Billadello JJ, Sobel BE.
    Thromb Haemost; 1990 Nov 30; 64(3):412-9. PubMed ID: 2128971
    [Abstract] [Full Text] [Related]

  • 13. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells.
    Thompson EA, Nelles L, Collen D.
    Eur J Biochem; 1991 Nov 01; 201(3):627-32. PubMed ID: 1935958
    [Abstract] [Full Text] [Related]

  • 14. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
    Peraldi MN, Rondeau E, Medcalf RL, Hagège J, Lacave R, Delarue F, Schleuning WD, Sraer JD.
    Biochim Biophys Acta; 1992 Apr 07; 1134(3):189-96. PubMed ID: 1558843
    [Abstract] [Full Text] [Related]

  • 15. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
    Morton PA, Owensby DA, Wun TC, Billadello JJ, Schwartz AL.
    J Biol Chem; 1990 Aug 25; 265(24):14093-9. PubMed ID: 2167306
    [Abstract] [Full Text] [Related]

  • 16. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
    Kooistra T, Bosma PJ, Toet K, Cohen LH, Griffioen M, van den Berg E, le Clercq L, van Hinsbergh VW.
    Arterioscler Thromb; 1991 Aug 25; 11(4):1042-52. PubMed ID: 1648385
    [Abstract] [Full Text] [Related]

  • 17. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.
    Dichek D, Quertermous T.
    Blood; 1989 Jul 25; 74(1):222-8. PubMed ID: 2502201
    [Abstract] [Full Text] [Related]

  • 18. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways.
    Konkle BA, Kollros PR, Kelly MD.
    J Biol Chem; 1990 Dec 15; 265(35):21867-73. PubMed ID: 1701436
    [Abstract] [Full Text] [Related]

  • 19. Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1.
    Li XK, Lijnen HR, Nelles L, Van Hoef B, Stassen JM, Collen D.
    Blood; 1992 Jan 15; 79(2):417-29. PubMed ID: 1730087
    [Abstract] [Full Text] [Related]

  • 20. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.
    van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ.
    Blood; 1988 Nov 15; 72(5):1467-73. PubMed ID: 3140909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.